RSPO3 and colorectal carcinoma: Increased stromal RSPO3 expression has also been observed in the absence of gene fusions and this stromal overexpression of RSPO3 is strongly associated with the aggressive mesenchymal consensus molecular subtype 4 (CMS4) CRC phenotype (Kleeman et al., 2020).